Literature DB >> 31154550

Multiclass Benchmarking Framework for Automated Acute Leukaemia Detection and Classification Based on BWM and Group-VIKOR.

M A Alsalem1,2, A A Zaidan3, B B Zaidan1, O S Albahri1, A H Alamoodi1, A S Albahri4, A H Mohsin5, K I Mohammed1.   

Abstract

This paper aims to assist the administration departments of medical organisations in making the right decision on selecting a suitable multiclass classification model for acute leukaemia. In this paper, we proposed a framework that will aid these departments in evaluating, benchmarking and ranking available multiclass classification models for the selection of the best one. Medical organisations have continuously faced evaluation and benchmarking challenges in such endeavour, especially when no single model is superior. Moreover, the improper selection of multiclass classification for acute leukaemia model may be costly for medical organisations. For example, when a patient dies, one such organisation will be legally or financially sued for incidents in which the model fails to fulfil its desired outcome. With regard to evaluation and benchmarking, multiclass classification models are challenging processes due to multiple evaluation and conflicting criteria. This study structured a decision matrix (DM) based on the crossover of 2 groups of multi-evaluation criteria and 22 multiclass classification models. The matrix was then evaluated with datasets comprising 72 samples of acute leukaemia, which include 5327 gens. Subsequently, multi-criteria decision-making (MCDM) techniques are used in the benchmarking and ranking of multiclass classification models. The MCDM used techniques that include the integrated BWM and VIKOR. BWM has been applied for the weight calculations of evaluation criteria, whereas VIKOR has been used to benchmark and rank classification models. VIKOR has also been employed in two decision-making contexts: individual and group decision making and internal and external group aggregation. Results showed the following: (1) the integration of BWM and VIKOR is effective at solving the benchmarking/selection problems of multiclass classification models. (2) The ranks of classification models obtained from internal and external VIKOR group decision making were almost the same, and the best multiclass classification model based on the two was 'Bayes. Naive Byes Updateable' and the worst one was 'Trees.LMT'. (3) Among the scores of groups in the objective validation, significant differences were identified, which indicated that the ranking results of internal and external VIKOR group decision making were valid.

Entities:  

Keywords:  Acute leukaemia; BWM; Benchmarking; Classification; Multiclass evaluation; VIKOR

Year:  2019        PMID: 31154550     DOI: 10.1007/s10916-019-1338-x

Source DB:  PubMed          Journal:  J Med Syst        ISSN: 0148-5598            Impact factor:   4.460


  10 in total

Review 1.  Real-Time Remote-Health Monitoring Systems: a Review on Patients Prioritisation for Multiple-Chronic Diseases, Taxonomy Analysis, Concerns and Solution Procedure.

Authors:  K I Mohammed; A A Zaidan; B B Zaidan; O S Albahri; M A Alsalem; A S Albahri; Ali Hadi; M Hashim
Journal:  J Med Syst       Date:  2019-06-11       Impact factor: 4.460

2.  A Systematic Review for Enabling of Develop a Blockchain Technology in Healthcare Application: Taxonomy, Substantially Analysis, Motivations, Challenges, Recommendations and Future Direction.

Authors:  H M Hussien; S M Yasin; S N I Udzir; A A Zaidan; B B Zaidan
Journal:  J Med Syst       Date:  2019-09-14       Impact factor: 4.460

3.  Realizing an Effective COVID-19 Diagnosis System Based on Machine Learning and IoT in Smart Hospital Environment.

Authors:  Karrar Hameed Abdulkareem; Mazin Abed Mohammed; Ahmad Salim; Muhammad Arif; Oana Geman; Deepak Gupta; Ashish Khanna
Journal:  IEEE Internet Things J       Date:  2021-01-11       Impact factor: 10.238

4.  Rescuing emergency cases of COVID-19 patients: An intelligent real-time MSC transfusion framework based on multicriteria decision-making methods.

Authors:  M A Alsalem; O S Albahri; A A Zaidan; Jameel R Al-Obaidi; Alhamzah Alnoor; A H Alamoodi; A S Albahri; B B Zaidan; F M Jumaah
Journal:  Appl Intell (Dordr)       Date:  2022-01-08       Impact factor: 5.019

5.  Novel dynamic fuzzy Decision-Making framework for COVID-19 vaccine dose recipients.

Authors:  O S Albahri; A A Zaidan; A S Albahri; H A Alsattar; Rawia Mohammed; Uwe Aickelin; Gang Kou; F M Jumaah; Mahmood M Salih; A H Alamoodi; B B Zaidan; Mamoun Alazab; Alhamzah Alnoor; Jameel R Al-Obaidi
Journal:  J Adv Res       Date:  2021-08-21       Impact factor: 12.822

6.  Optimal Deep Transfer Learning-Based Human-Centric Biomedical Diagnosis for Acute Lymphoblastic Leukemia Detection.

Authors:  Manar Ahmed Hamza; Amani Abdulrahman Albraikan; Jaber S Alzahrani; Sami Dhahbi; Isra Al-Turaiki; Mesfer Al Duhayyim; Ishfaq Yaseen; Mohamed I Eldesouki
Journal:  Comput Intell Neurosci       Date:  2022-05-30

Review 7.  The Promise of AI in Detection, Diagnosis, and Epidemiology for Combating COVID-19: Beyond the Hype.

Authors:  Musa Abdulkareem; Steffen E Petersen
Journal:  Front Artif Intell       Date:  2021-05-14

8.  PSO-Blockchain-based image steganography: towards a new method to secure updating and sharing COVID-19 data in decentralised hospitals intelligence architecture.

Authors:  A H Mohsin; A A Zaidan; B B Zaidan; K I Mohammed; O S Albahri; A S Albahri; M A Alsalem
Journal:  Multimed Tools Appl       Date:  2021-01-22       Impact factor: 2.757

9.  An integrated multi-criteria decision-making approach for identifying the risk level of musculoskeletal disorders among handheld device users.

Authors:  Rahul Jain; Kunj Bihari Rana; Makkhan Lal Meena
Journal:  Soft comput       Date:  2021-02-03       Impact factor: 3.643

Review 10.  The perspectives of biomarker-based electrochemical immunosensors, artificial intelligence and the Internet of Medical Things toward COVID-19 diagnosis and management.

Authors:  A K Yadav; D Verma; A Kumar; P Kumar; P R Solanki
Journal:  Mater Today Chem       Date:  2021-02-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.